Leptomeningeal Metastases: New Opportunities in the Modern Era
Open Access
- 5 July 2022
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 19 (6) , 1782-1798
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P30 CA008748)
This publication has 182 references indexed in Scilit:
- Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumabJournal of Neurology, 2012
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast CancerNew England Journal of Medicine, 2012
- Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastomaNeuro-Oncology, 2012
- Leptomeningeal metastases in the MRI eraNeurology, 2010
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALKJournal of Clinical Oncology, 2009
- Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast CancerClinical Cancer Research, 2009
- A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignanciesNeuro-Oncology, 2008
- Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical featuresNeuro-Oncology, 2008
- Capecitabine Therapy of Central Nervous System Metastases from Breast CancerJournal of Neuro-Oncology, 2007
- Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinomaCancer, 2003